Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany

Hepatology Research

Volumn 13, Issue 3, 1999, Pages 205-211

  Schröter, Matthias ^a   Feucht, Heinz Hubert ^a   Zöllner, Bernhard ^a   Barbel Knodler ^b   Schäfer, Peter ^a   Fischer, Lutz ^a   Laufs, Rainer ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Medizinische Klinik   (Germany)

Author keywords

Hepatitis; PCR; Risk factors; TTV

Indexed keywords

ALANINE AMINOTRANSFERASE; LIVER ENZYME; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA VIRUS; FEMALE; GERMANY; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; VIREMIA;

EID: 0345130089     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00091-6     Document Type: Article

References (12)

1. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. New Engl J Med 1992;327:1899-1905.
2. Alter MJ, Gallagher M, Morris T, et al. Epidemiology of non A- non E hepatitis. In: IX Triennial International Symposium on Viral Hepatitis and Liver Disease 1996, Rome, Italy, p. 34.
3. Feucht HH, Zöllner B, Polywka S, et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol 1997;35:767-768.
4. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-97.
5. Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with post-transfusion hepatitis of unknown etiology. Hepatol Res 1998;10:1-16.
6. Schröter M, Feucht HH, Schäfer P, Zöllner B, Laufs R. High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology 1997;40:277-278.
7. Liang TJ, Bodenheimer Jr. HC, Yankee R, et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Virol 1994;42:151-157.
8. Feucht HH, Zöllner B, Polywka S, et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997;26:491-494.
9. Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Association of antibody to GB Virus C (Hepatitis G Virus) with viral clearence and protection from reinfection. J Infect Dis 1998;177:539-542.
10. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998;352:195-197.
11. Simmonds P, Davidson F, Lycett C, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998;352:191-195.
12. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B 19 infection associated with acute hepatitis. Lancet 1996;347:868-869.